User profiles for Daniel Henderson

Daniel J. Henderson

J. Weldon and Delores Cole Faculty Fellow, University of Alabama
Verified email at ua.edu
Cited by 4007

Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system

E Zimlichman, D Henderson, O Tamir… - JAMA internal …, 2013 - jamanetwork.com
Importance Health care–associated infections (HAIs) account for a large proportion of the
harms caused by health care and are associated with high costs. Better evaluation of the costs …

Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells

…, HY Lim, GA Henderson, JW Simons, DR Henderson - Cancer research, 1997 - AACR
Prostate-specific antigen (PSA) is a widely used marker for the diagnosis and management
of prostate cancer. Minimal enhancer/promoter constructs derived from the 5′ flank of the …

Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells

…, MEG Kranendonk, DE Henderson… - Proceedings of the …, 2011 - National Acad Sciences
The intestinal epithelium is maintained by a population of rapidly cycling (Lgr5 + ) intestinal
stem cells (ISCs). It has been postulated, however, that slowly cycling ISCs must also be …

[HTML][HTML] Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international …

…, J Frew, A Chan, IS Dayes, D Henderson… - The Lancet …, 2019 - thelancet.com
Background Localised prostate cancer is commonly treated with external-beam radiotherapy.
Moderate hypofractionation has been shown to be non-inferior to conventional fractionation…

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy

…, S Piantadosi, DC Yu, Y Chen, DR Henderson… - Cancer research, 2001 - AACR
CV706 is a prostate-specific antigen (PSA)-selective, replication-competent adenovirus that
has been shown to selectively kill human prostate cancer xenografts in preclinical models. …

[HTML][HTML] Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised …

…, IS Dayes, A Duffton, DH Brand, D Henderson… - The Lancet …, 2022 - thelancet.com
Background Localised prostate cancer is commonly treated with external beam radiotherapy
and moderate hypofractionation is non-inferior to longer schedules. Stereotactic body …

Human capital and convergence: a production‐frontier approach

DJ Henderson, RR Russell - International Economic Review, 2005 - Wiley Online Library
Using nonparametric, production‐frontier methods, we decompose labor productivity growth
into components attributable to technological change (shifts in the world production frontier), …

[BOOK][B] Applied nonparametric econometrics

DJ Henderson, CF Parmeter - 2015 - books.google.com
The majority of empirical research in economics ignores the potential benefits of nonparametric
methods, while the majority of advances in nonparametric theory ignores the problems …

Nonparametric estimation and testing of fixed effects panel data models

DJ Henderson, RJ Carroll, Q Li - Journal of Econometrics, 2008 - Elsevier
In this paper we consider the problem of estimating nonparametric panel data models with
fixed effects. We introduce an iterative nonparametric kernel estimator. We also extend the …

Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence: a multi-institutional analysis

…, N Van As, T Zilli, A Muacevic, K Olivier, D Henderson… - European urology, 2016 - Elsevier
The literature on metastasis-directed therapy for oligometastatic prostate cancer (PCa)
recurrence consists of small heterogeneous studies. This study aimed to reduce the …